64 results
Keyword Erbitux Remove keyword
-
List item
Annual reports and work programmes
Last updated: 28/06/2023 -
List item
Committee for Advanced Therapies (CAT) workshop: scientific and regulatory challenges of genetically modified cell-based cancer immunotherapy products
European Medicines Agency, London, UK, from 15/11/2016 to 16/11/2016, Last updated: 08/11/2016Eli Lilly 2.5 billion 9. Erbitux Cetuximab, monoclonal Ab … -
List item
CHMP: meeting archive 2010-2012
Last updated: 17/12/2013 -
List item
Committee for Medicinal Products for Human Use (CHMP): 13-16 December 2021
European Medicines Agency, Amsterdam, the Netherlands, from 13/12/2021 to 16/12/2021, Last updated: 04/11/2019 -
List item
Committee for Medicinal Products for Human Use (CHMP): 18-21 July 2022
European Medicines Agency, Amsterdam, the Netherlands, from 18/07/2022 to 21/07/2022, Last updated: 06/04/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 12-15 September 2022
European Medicines Agency, Amsterdam, the Netherlands, from 12/09/2022 to 15/09/2022, Last updated: 06/04/2021 -
List item
Press release: European Medicines Agency publishes 2012 annual report
Last updated: 16/04/2013 -
List item
News: Annual report 2011 shows continuously high level of activities
Last updated: 06/06/2012 -
List item
News: Annual report 2009 published: "Agency achieved very good results in one of the most challenging years in its history"
Last updated: 20/05/2010 -
List item
Management Board meeting: 21-22 March 2012
European Medicines Agency, London, UK, from 21/03/2012 to 22/03/2012, Last updated: 08/09/2011 -
List item
Similar biological medicinal products - Scientific guideline
Last updated: 30/10/2005 -
List item
Committee for Medicinal Products for Human Use (CHMP): 11-14 September 2017
European Medicines Agency, London, UK, from 11/09/2017 to 14/09/2017, Last updated: 06/01/2014 -
List item
PRAC: meeting archive 2015-2017
Last updated: 13/05/2016 -
List item
CHMP: meeting archive 2016-2018
Last updated: 26/02/2020